Vienna
Austria
Medical University of Vienna - Department of Obstetrics and Gynecology
adverse events, coronavirus, COVID-19, pandemic, postpartum, SARS-CoV-2
HER2/CEP17 ratio, early-stage breast cancer, neoadjuvant dual HER2 blockade, residual cancer burden, HER2 positivity